C. Lévi

ORCID: 0000-0001-9228-946X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Calpain Protease Function and Regulation
  • Vasculitis and related conditions
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Bacterial Infections and Vaccines
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Melanoma and MAPK Pathways
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Renal Diseases and Glomerulopathies
  • COVID-19 Impact on Reproduction
  • Signaling Pathways in Disease
  • Nephrotoxicity and Medicinal Plants
  • interferon and immune responses
  • Sarcoidosis and Beryllium Toxicity Research
  • Pediatric Urology and Nephrology Studies
  • Abdominal vascular conditions and treatments
  • Organ Donation and Transplantation
  • Fungal Infections and Studies
  • Infectious Disease Case Reports and Treatments
  • Bone health and treatments
  • Renal and Vascular Pathologies
  • Parathyroid Disorders and Treatments
  • Cytomegalovirus and herpesvirus research
  • Otitis Media and Relapsing Polychondritis
  • Vibrio bacteria research studies

Hospices Civils de Lyon
2019-2023

Hôpital Edouard Herriot
2021-2023

HCL Technologies (India)
2023

Sorbonne Université
2011-2015

Inserm
2011-2015

Délégation Paris 5
2014

Hôpital Européen
2012-2014

Hôpital Européen Georges-Pompidou
2014

Université Paris Cité
2014

Centre National de la Recherche Scientifique
2011

Transplant recipients, who receive therapeutic immunosuppression to prevent graft rejection, are characterized by high coronavirus disease 2019 (COVID-19)-related mortality and defective response vaccines. We observed that previous infection with severe acute respiratory syndrome 2 (SARS-CoV-2), but not the standard two-dose regimen of vaccination, provided protection against symptomatic COVID-19 in kidney transplant recipients. therefore compared cellular humoral immune responses these two...

10.1126/scitranslmed.abl6141 article EN Science Translational Medicine 2022-02-01

Sepsis, a leading cause of death worldwide, involves widespread activation inflammation, massive coagulation, and lymphocyte apoptosis. Calpains, calcium-activated cysteine proteases, have been shown to increase inflammatory reactions Moreover, calpain plays an essential role in microparticle release.We investigated the contribution eliciting tissue damage during sepsis.To test our hypothesis, we induced polymicrobial sepsis by cecal ligation puncture wild-type (WT) mice transgenic...

10.1164/rccm.201109-1686oc article EN American Journal of Respiratory and Critical Care Medicine 2012-01-21

Kidney transplant recipients develop atypical infections in their epidemiology, presentation and outcome. Among these, meningitis meningoencephalitis require urgent adapted anti-infectious therapy, but published data is scarce KTRs. The aim of this study was to describe outcome, order improve diagnostic management. We performed a retrospective, multicentric cohort 15 French hospitals that included all 199 cases M/ME KTRs between 2007 2018 (0.9 case per 1,000 annually). Epidemiology different...

10.3389/ti.2023.10765 article EN cc-by Transplant International 2023-01-18

Calpains, calcium-activated proteases, mediate the angiogenic signals of vascular endothelial growth factor. However, their involvement in repair has not been investigated and underlying mechanisms remain to be fully elucidated.A rapidly progressive form glomerulonephritis wild type transgenic mice expressing high levels calpastatin, a calpain-specific inhibitor, was studied. Calpastatin transgene expression prevented peritubular capillaries recovery renal function, limiting mouse survival....

10.1161/atvbaha.111.240242 article EN Arteriosclerosis Thrombosis and Vascular Biology 2011-11-18

Calpains are intracellular proteases that play a key role in inflammation/immunity. Rare studies show they partially externalized. However, the mechanism of this secretion and functions exteriorized calpains remain poorly understood. In study, we found mouse human lymphocytes secreted through an ABCA1-driven process. turn, extracellular inhibited IL-17A expression. We were able to attribute function cleavage TLR2 domain, which prevented TLR2-induced transcription molecules essential for...

10.4049/jimmunol.1500749 article EN The Journal of Immunology 2015-11-26

Informing kidney transplant recipients of their prognosis and disease progression is primary importance in a patient-centred vision care. By participating decisions from the outset, may be more adherent to complex medical regimens due enhanced understanding.We proposed include repeated measurements serum creatinine (SCr), addition baseline characteristics, order obtain dynamic predictions graft failure risk that could updated continuously during patient follow-up. Adult French Données...

10.1093/ndt/gfz027 article EN Nephrology Dialysis Transplantation 2019-02-08

lyzing group A streptococci, notably without prior drug intake.Again, intraoral pustules were observed.During this episode, clinical and histologic findings consistent with GPP. 1 The patient recalled a similar episode 20 years before generalized pustular eruption systemic symptoms intake.The was given oral clarithromycin (500 mg twice daily) for his throat infection 2 infusions infliximab (5 mg/kg of body weight), which resulted in rapid clearance the lesions.Discussion | Our presented...

10.1001/jamadermatol.2014.4529 article EN JAMA Dermatology 2014-12-10

Abstract Transplant recipients, which receive therapeutic immunosuppression to prevent graft rejection, are characterized by high COVID-19-related mortality and defective response vaccines. Having observed that previous infection SARS-CoV-2 but not the standard “2 doses” scheme of vaccination, provided complete protection against COVID-19 transplant we undertook this translational study compare cellular humoral immune responses these 2 groups patients. Neutralizing anti-Receptor Binding...

10.1101/2021.07.22.21260852 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-07-24

Little is known regarding the optimal management of nocardiosis among solid organ transplant (SOT) recipients. It often suggested to avoid trimethoprim/sulfamethoxazole (TMP-SMX) monotherapy in heavily immunocompromised patients (such as SOT recipients) and/or case severe or disseminated nocardiosis. Our aim was report our experience with TMP-SMX recipients nocardiosis.Using data from a previously published European study, we assessed incidence adverse events receiving and its...

10.1111/tid.13669 article EN Transplant Infectious Disease 2021-06-18

Abstract Background and Aims Outcomes of kidney transplantation for patients with renal AA amyloidosis are uncertain, reports poor survival high allograft recurrence. However, recent advances in biotherapies, especially anti-IL-1 treatments, may have improved patients’ outcome the setting. Method We conducted a retrospective multicenter matched cohort study 26 French centers reporting all who received transplant between 2008 2018, compared them to control (ratio 1:2 controls) other causes...

10.1093/ndt/gfad063c_6894 article EN Nephrology Dialysis Transplantation 2023-06-01

Abstract Background Mineral bone disorders associated to chronic kidney disease (CKD-MBD) frequently persist after renal transplantation (R-Tx), being due pre-existing CKD-MBD, immunosuppressive therapies and post-Tx hypophosphatemia. We aimed evaluate biomarkers microarchitecture at the time of 6 months R-Tx. Methods Here we present single-center sub-group patients included between 10 18 years age from prospective TRANSOS study (NCT02729142). Patients undergoing a first R-Tx were matched on...

10.21203/rs.3.rs-3763742/v1 preprint EN cc-by Research Square (Research Square) 2023-12-20
F. Marie-Lucile N. Laure-Helene C. Yosr Mc Leer Anne Fadi Francis and 95 more C. Lévi C. Levi Vannary Meas‐Yedid Constantin G. Daniliuc Alexandre Karras Jean‐Christophe Olivo‐Marín L. Mouthon E. Guiard Michelle E. Roland L. Guillevin C. Jacquot Dominique Nochy Éric Thervet Q. Chen C. Skerka Barbara Uzonyi Simon Lindner Christoph Licht Bernd Höppe Magdalena Riedl Michael Kirschfink S. Habbich G. Wolf Lisa Strain Timothy H.J. Goodship P. F. Zipfel Hala Kfoury Abdulkareem Alsuwaida Khaled O. Alsaad Faris Alhejaili M. Alghonaim Jamal Al-Wakeel S. Husain N. Aloudah Luca Besso Luca Besso M. Tamagnone Germana Daidola M. Burdese Lorenzo Repetto Giuseppe Di Pasquale Loredana Colla Luigi Biancone P. Stratta G. P. Segoloni Jasna Bacalja Ana Marija Bauer Šegvić Stela Bulimbašić Arijana Pačić Mladen Knotek Mirjana Sabljar Matovinović Kres̆imir Gales̃ić Danica Galešić Ljubanović Elena Zakharova E. Stolyarevich Olga Vorobjova H. Tamouza Jonathan Chemouny M. Flamant Leona Rašková Kafková Marie Demion Laurent Mesnard F. Walker Bruce A. Julian E. Tissandié Manish Kumar Tiwari Jan Novák N. O. Camara M. Benhamou F. Vrtovsnik Renato C. Monteiro I. C. Moura Shiva Samavat Pedram Ahmadpoor Peyman Mohammadi Torbati Reza Ghaderi Fatemeh Poorrezagholi Fariba Samadian Mohsen Nafar A. MII A. MII Akira Shimizu Takahide Kaneko F. Yasuda Masaki Fukui Yuichi Masuda Y. Iino Y. Katayama Clemens Müller Jasmina Markovic‐Lipkovski S. Simic-Ogrizovic Radomir Naumović Sanja Ćirović Dragan Mitrović Gerhard A. Müller

10.1093/ndt/gfs242 article EN Nephrology Dialysis Transplantation 2012-05-01

Abstract Background The management of meningitis requires the prompt introduction high-dose probabilistic anti-infectious therapy. literature reporting on in kidney transplant recipients (KTR) is scarce and no recommendation exists for this specific population. Methods We retrospectively included all adult KTRs diagnosed with (cerebro-spinal fluid (CSF) cell count >10/mm3 or positive fungal antigen direct examination) between 2007 2018 16 French hospitals. Clinical, biological,...

10.1093/ofid/ofz360.2336 article EN cc-by-nc-nd Open Forum Infectious Diseases 2019-10-01
Coming Soon ...